With this tool, disruption of the critical C3d-CR2 ligand-receptor binding step alone substantially delayed autoimmunity and renal disease progression in the MRL/lpr model of SLE (Fig. 1C) (Kulik et al., 2019). The gene discussed is CR2; the disease is systemic lupus erythematosus.